Navigation Links
UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting

YOQNEAM, Israel and SAN RAMON, California, April 3 /PRNewswire/ -- Results of an independent multi-treatment clinical study of the UltraShape(R) Contour I, the first clinically proven non-invasive solution for fat reduction and body contouring using non-thermal selective focused ultrasound will be presented at the American Society for Laser Medicine and Surgery annual meeting on April 4, 2008 in Kissimmee, Florida. The presentation is entitled "Lipotripsy: Non-invasive Ultrasonic Selective Destruction of Adipocytes using UltraShape" will take place during the scientific session The Cutting Edge in Optical Diagnostics and Therapeutics of Tissues and Cells.

Hector Leal-Silva, M.D., a dermatologic surgeon based in Monterrey, Mexico, will present the results of the 36 patient clinical study using the UltraShape system on localized fat deposits in the abdomen, flanks, and thighs. The study showed definitive, measurable results in 100 percent of patients including an average of two-inch (5cm) reduction in circumference in the abdomen after a series of three treatments, one month apart. CT scans taken in a subset of study subjects showed objective quantifiable fat thickness reduction. Photographic assessment, weight and circumferential measures were evaluated before and after each treatment and one month after the last treatment. Visual contour improvement was seen in over 85% of patients as assessed by an independent panel of physicians. Ninety-four percent (94%) of patients were satisfied with the procedure. In addition, there were no adverse events reported.

"With the major shift in patient demand toward non-invasive, pain-free, no-downtime procedures UltraShape has become a core procedure offering in my aesthetic practice," said Leal. "My clinical study demonstrated measurable circumference reduction and visual improvement in body contour in all patients. Moreover, my patients are happy with a high percentage of them returning for treatment of other body areas or recommending UltraShape to friends and family."

"Dr. Leal-Silva's impressive clinical study results combined with his successful commercial experience with UltraShape further adds to our growing body of evidence supporting UltraShape as the clinically proven non-invasive option for the reduction of localized fat deposits and improvement in body contour," said Rodger Stewart, President and Chief Executive Officer of UltraShape Inc.

About the UltraShape(R) Contour I

The UltraShape Contour I system, based on patented focused ultrasound technology, is the first scientifically and clinically proven non-invasive fat reduction and body contouring solution for both men and women. The device produces mechanical, non-thermal, acoustic effects which target and selectively destroy fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guarantees adherence to a pre-determined treatment algorithm minimizing risk of contour irregularities, a common side effect of liposuction. The UltraShape procedure is performed during a convenient, "walk-in, walk-out" session carried out in an office-based environment; it requires no anesthesia or sedation, and the vast majority of patients report no pain or discomfort. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape procedure is available in 50 countries and over 55,000 patient treatments have been performed worldwide with high patient satisfaction. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The UltraShape Contour I system is not available for sale in the United States.

About UltraShape(R)

UltraShape is redefining aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for body contouring. The company is dedicated to providing clinically proven safe and effective solutions that enhance the lives of patients worldwide. The UltraShape proprietary non-invasive body contouring technology is based on focused ultrasound that targets and selectively disrupts fat cells without affecting surrounding structures. Founded in 2000, UltraShape is a privately held and venture backed company with offices in the United States, Israel, France, United Kingdom, and Italy. For more information visit


Abigail Marks Paula Moggio Jessica Fishman

UltraShape FischerHealth Gitam Porter Novelli

+972-4-909-9260 +1-310-577-7870 x151 +972-3-576-5798

SOURCE UltraShape Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
2. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
3. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
4. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
5. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
6. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
7. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
8. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
9. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
10. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
11. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
Post Your Comments:
(Date:11/24/2015)... -- The uptake of recently approved and pipeline premium products ... market growth to 2021, says GBI Research . ... for Type 1 Diabetes Mellitus (T1DM), will be a key driver of ... --> The uptake of recently approved and pipeline premium ... of market growth to 2021, says GBI Research ...
(Date:11/24/2015)... 24, 2015   Renowned ... deliver s advice and insights on ... More than 50% of Dubai ... according to the DHA   femMED launches comprehensive solutions for ... Dubai residents are not consuming enough to keep ...
(Date:11/24/2015)...  Freudenberg Medical has developed specialty tubing for an inexpensive, ... facilities. Africa and ... Nevertheless, prompt diagnosis is important to treat those affected and ... the help of a portable mini-lab or "lab on a ... affected areas and perform rapid testing for HIV. They do ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... ... announces Fragrance by Marcelle, a cosmetic invention which offers a combination of natural ... Market in the US is worth $3 billion annually," says Scott Cooper, CEO ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the Business Action on Health Awards, bestowed annually to the world’s best corporate-supported ... commended companies at Global Health Council’s Landscape Symposium held in Washington D.C and ...
(Date:11/24/2015)... ... November 24, 2015 , ... The OSHA Training ... Institute Education Center in Northern California, is calling on retail employers to implement ... As the volume of sales and shoppers rapidly expands, retailers are strongly ...
(Date:11/24/2015)... ... 24, 2015 , ... There’s nothing better than giving the gift of green ... enjoy. , This year, gardens are popping up in the most unexpected places. ... , Vita Gardens’ African Keyhole Garden Bed ($499) , Water conscious gardeners – and ...
(Date:11/24/2015)... ... November 24, 2015 , ... Wireless Analytics, ... today announced new 24-hour weekday support capability. The “all hours” offering was ... Analytics’ international customers, and to enhance after-hours support available in the US. , ...
Breaking Medicine News(10 mins):